S-Alpha Therapeutics Inc. announced that it has received KRW 11,000,000,000 in a round of funding led by, LB Investment Inc., Mirae Asset Capital Co,Ltd., Investment Arm, returning investors, Korea Investment Partners Co. Ltd., Tony Investment Co., Ltd., CJ Investment Inc. and Hana Ventures Inc. and on March 29, 2023. The company has raised KRW 24,619,047,619 in funding till date.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
5,480 KRW | -1.26% | -10.02% | +17.72% |
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+17.72% | 93.13M | |
+16.14% | 3.1B | |
+12.82% | 1.77B | |
+9.42% | 1.52B | |
-11.54% | 1.2B | |
+16.35% | 771M | |
+10.17% | 671M | |
+31.22% | 562M | |
-4.17% | 505M | |
+27.48% | 472M |
- Stock Market
- Equities
- A309960 Stock
- News LB Investment Inc.
- S-Alpha Therapeutics Inc. announced that it has received KRW 11 billion in funding from Korea Investment Partners Co. Ltd., Tony Investment Co., Ltd., CJ Investment Inc., Hana Ventures Inc., Mirae Asset Capital Co,Ltd., Investment Arm, LB Investment Inc.